Il y a eu 50 transactions d'initiés récentes enregistrées pour Spruce Biosciences, Inc. (SPRB), dont 20 achats et 27 ventes. Le total des achats d'initiés s'élève à $677.67K et le total des ventes d'initiés à $8.74M.
Les initiés notables ayant une activité récente comprennent Hooks Corwin Dale, Szwarcberg Javier B., Gharib Samir M.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — SPRB
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-09 |
Hooks Corwin Dale |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-09 |
Hooks Corwin Dale |
Chief Commercial Officer |
Attribution de RSU |
11,000 |
- |
- |
11,000 |
| 2025-12-31 |
Szwarcberg Javier B. |
Chief Executive Officer |
Attribution de RSU |
4,690 |
$4.53 |
$21.25K |
19,004 |
| 2025-12-15 |
Gharib Samir M. |
President and CFO |
Exercice d'Options (Vente) |
496 |
- |
- |
497 |
| 2025-12-15 |
Szwarcberg Javier B. |
Chief Executive Officer |
Exercice d'Options (Vente) |
1,480 |
- |
- |
1,480 |
| 2025-12-11 |
Ways Douglas Kirk |
Interim Chief Medical Officer |
Restitution d'Actions |
400 |
$169.50 |
$67.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Exercice d'Options (Vente) |
1,900 |
- |
- |
5,700 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Retenue Fiscale RSU |
2,194 |
$88.41 |
$193.97K |
12,998 |
| 2025-12-11 |
Spiegelman Daniel K |
Director |
Restitution d'Actions |
458 |
$564.00 |
$258.31K |
- |
| 2025-12-11 |
Grey Michael G |
Executive Chairman |
Restitution d'Actions |
387 |
$108.00 |
$41.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Restitution d'Actions |
733 |
$1,506.00 |
$1.1M |
- |
| 2025-12-11 |
Simpson Camilla V |
Director |
Restitution d'Actions |
173 |
$108.00 |
$18.68K |
- |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Restitution d'Actions |
10,000 |
$344.25 |
$3.44M |
- |
| 2025-12-11 |
Barretto-ko Percival |
Director |
Restitution d'Actions |
800 |
$169.50 |
$135.6K |
- |
| 2025-12-11 |
Walbert Keli |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-12-11 |
Walbert Keli |
Director |
Attribution de RSU |
3,400 |
$88.41 |
$300.59K |
3,400 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Attribution de RSU |
1,666 |
$104.13 |
$173.48K |
1,666 |
| 2025-12-10 |
Gharib Samir M. |
President and CFO |
Exercice d'Options (Vente) |
514 |
- |
- |
1,539 |
| 2025-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
Exercice d'Options (Vente) |
1,196 |
- |
- |
3,588 |
| 2025-10-20 |
Gharib Samir M. |
President and CFO |
Exercice d'Options (Vente) |
2,053 |
- |
- |
- |
| 2025-10-20 |
Szwarcberg Javier B. |
Chief Executive Officer |
Exercice d'Options (Vente) |
4,784 |
- |
- |
- |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Inconnu |
- |
- |
- |
1,051 |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Vente Informative |
25 |
$17.46 |
$436.39 |
1,050 |
| 2025-07-23 |
Ways Kirk |
Interim Chief Medical Officer |
Attribution de RSU |
30,000 |
$0.12 |
$3.71K |
30,000 |
| 2025-07-22 |
Spiegelman Daniel K |
Director |
Attribution de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Grey Michael G |
Executive Chairman |
Attribution de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Aynechi Tiba |
Director |
Attribution de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Muralidhar Bali |
Director |
Attribution de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Simpson Camilla V |
Director |
Attribution de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Barretto-ko Percival |
Director |
Attribution de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2024-12-16 |
Gharib Samir M. |
President and CFO |
Exercice d'Options (Vente) |
37,250 |
- |
- |
74,500 |
| 2024-12-16 |
Szwarcberg Javier B. |
Chief Executive Officer |
Exercice d'Options (Vente) |
111,000 |
- |
- |
222,000 |
| 2024-12-16 |
Charlton Ralph William Iii |
Chief Medical Officer |
Exercice d'Options (Vente) |
31,750 |
- |
- |
63,500 |
| 2024-12-10 |
Gharib Samir M. |
President and CFO |
Exercice d'Options (Vente) |
154,000 |
- |
- |
154,000 |
| 2024-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
Retenue Fiscale RSU |
128,020 |
$0.54 |
$68.75K |
338,101 |
| 2024-12-10 |
Charlton Ralph William Iii |
Chief Medical Officer |
Exercice d'Options (Vente) |
106,400 |
- |
- |
106,400 |
| 2024-05-22 |
Spiegelman Daniel K |
Director |
Attribution de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Grey Michael G |
Executive Chairman |
Attribution de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Aynechi Tiba |
Director |
Attribution de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Muralidhar Bali |
Director |
Attribution de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Simpson Camilla V |
Director |
Attribution de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Ways Kirk |
Director |
Attribution de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Barretto-ko Percival |
Director |
Attribution de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-03-21 |
Novo Holdings A/s |
10 Percent Owner |
Vente Informative |
465,021 |
$0.75 |
$350.95K |
2,550,000 |
| 2024-03-20 |
Novo Holdings A/s |
10 Percent Owner |
Vente Informative |
359,979 |
$0.73 |
$264.08K |
3,015,021 |
| 2024-03-19 |
Novo Holdings A/s |
10 Percent Owner |
Vente Informative |
593,000 |
$0.76 |
$447.72K |
3,375,000 |
| 2024-03-18 |
Novo Holdings A/s |
10 Percent Owner |
Vente Informative |
842,020 |
$0.77 |
$647.01K |
3,968,000 |
| 2024-03-14 |
Novo Holdings A/s |
10 Percent Owner |
Vente Informative |
1,912,316 |
$0.89 |
$1.7M |
4,810,020 |
| 2024-03-14 |
Gharib Samir M. |
President and CFO |
Attribution de RSU |
154,000 |
- |
- |
154,000 |
| 2024-03-14 |
Szwarcberg Javier B. |
Chief Executive Officer |
Attribution de RSU |
358,800 |
- |
- |
358,800 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
